![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kim Jung-Ae Neupane Ganesh Prasad Lee Eung Seok Jeong Byeong-Seon Park Byung Chul Thapa Pritam
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.21, Iss.8, 2011-08, pp. : 1147-1158
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Xanthine oxidase inhibitors: a patent survey
By Kumar Raj Sharma Sahil Singh Rajveer
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tubulin inhibitors: a patent review
By Liu Yi-Min Chen Hsiao-Ling Lee Hsueh-Yun Liou Jing-Ping
Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Selectin inhibitors: a patent review
By Bedard Patricia W Kaila Neelu
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Itk inhibitors: a patent review
By Lo Ho Yin
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 4, 2010-04 ,pp. :